Botryorhodines K and L, two new cytotoxic depsidones from a fungus of the genus Arcopilus

Zhang, Zhiwei; Ge, Yiwei; In, Yasuko; Igarashi, Yasuhiro

doi:10.1038/s41429-023-00652-9

Cited by 1 publication

(1 citation statement)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…When referring to natural enzymes, it should be noted that they are delicate by nature and cannot withstand digestion combinations, ideal pH, or poor heat stability. [17] The goal of photodynamic treatment (PDT) and prodrug synergy is to produce hypoxia by generating free radicals from molecular oxygen and activating the prodrug at the same time, in addition to the effective delivery of hypoxia-activated prodrugs with better performance. [18,19] Cancer starvation therapy, an emerging tactic, is based on the premise that tumor proliferation can be inhibited by cutting off the availability of nutrients.…”

Section: Introductionmentioning

confidence: 99%

Dual Enzyme‐Encapsulated Materials for Biological Cascade Chemistry and Synergistic Tumor Starvation

Mishra,

Dutta

2024

Chemistry A European J

View full text Add to dashboard Cite

Framework and polymeric nanoreactors (NRs) have distinct advantages in improving chemical reaction efficiency in the tumor microenvironment (TME). Nanoreactor‐loaded oxidoreductase enzyme is activated by tumor acidity to produce H2O2 by increasing tumor oxidative stress. High levels of H2O2 induce self‐destruction of the vesicles by releasing quinone methide to deplete glutathione and suppress the antioxidant potential of cancer cells. Therefore, the synergistic effect of the enzyme‐loaded nanoreactors results in efficient tumor ablation via suppressing cancer‐cell metabolism. The main driving force would be to take advantage of the distinct metabolic properties of cancer cells along with the high peroxidase‐like activity of metalloenzyme/metalloprotein. A cascade strategy of dual enzymes such as glucose oxidase (GOx) and nitroreductase (NTR) wherein the former acts as an O2‐consuming agent such as overexpression of NTR and further amplified NTR‐catalyzed release for antitumor therapy. The design of cascade bioreductive hypoxia‐responsive drug delivery via GOx regulates NTR upregulation and NTR‐responsive nanoparticles. Herein, we discuss tumor hypoxia, reactive oxygen species (ROS) formation, and the effectiveness of these therapies. Nanoclusters in cascaded enzymes along with chemo‐radiotherapy with synergistic therapy are illustrated. Finally, we outline the role of the nanoreactor strategy of cascading enzymes along with self‐synergistic tumor therapy.

show abstract

Section: Introductionmentioning

confidence: 99%